Citigroup’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $133K | Sell |
|
|||||
|
2025
Q2 | $4.16M | Buy |
|
|||||
|
2025
Q1 | $1.82M | Buy |
|
|||||
|
2024
Q4 | $276K | Sell |
|
|||||
|
2024
Q3 | $326K | Buy |
|
|||||
|
2024
Q2 | $85.1K | Buy |
|
|||||
|
2024
Q1 | $48.3K | Buy |
|
|||||
|
2023
Q4 | $39.1K | Buy |
|
|||||
|
2023
Q3 | $5.67K | Sell |
|
|||||
|
2023
Q2 | $755K | Sell |
|
|||||
|
2023
Q1 | $1.51M | Buy |
|
|||||
|
2022
Q4 | $798K | Sell |
|
|||||
|
2022
Q3 | $1.58M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $932K | Sell |
|
|||||
|
2021
Q4 | $2.38M | Buy |
|
|||||
|
2021
Q3 | $1.6M | Sell |
|
|||||
|
2021
Q2 | $2.99M | Sell |
|
|||||
|
2021
Q1 | $2.9M | Buy |
|
|||||
|
2020
Q4 | $219K | Buy |
|
|||||
|
2020
Q3 | $60K | Sell |
|
|||||
|
2020
Q2 | $674K | Buy |
|
|||||
|
2020
Q1 | $443K | Buy |
|
|||||
|
2019
Q4 | $480K | Sell |
|
|||||
|
2019
Q3 | $1.71M | Buy |
|
|||||
|
2019
Q2 | $1.66M | Buy |
|
|||||
|
2019
Q1 | $1.06M | Sell |
|
|||||
|
2018
Q4 | $2.03M | Buy |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $43K | Buy |
|
|||||
|
2018
Q1 | $29K | Sell |
|
|||||
|
2017
Q4 | $1.35M | Sell |
|
|||||
|
2017
Q3 | $2.29M | Buy |
|
|||||
|
2017
Q2 | $759K | Buy |
|
|||||
|
2017
Q1 | $456K | Sell |
|
|||||
|
2016
Q4 | $2.21M | Buy |
|
|||||
|
2016
Q3 | $351K | Buy |
|
|||||
|
2016
Q2 | $72K | Sell |
|
|||||
|
2016
Q1 | $305K | Buy |
|
|||||
|
2015
Q4 | $63K | Sell |
|
|||||
|
2015
Q3 | $523K | Buy |
|
|||||
|
2015
Q2 | $146K | Buy |
|
|||||
|
2015
Q1 | $78K | Sell |
|
|||||
|
2014
Q4 | $219K | Buy |
|
|||||
|
2014
Q3 | $12K | Sell |
|
|||||
|
2014
Q2 | $71K | Sell |
|
|||||
|
2014
Q1 | $140K | Sell |
|
|||||
|
2013
Q4 | $162K | Buy |
|
|||||
|
2013
Q3 | $102K | Buy |
|
|||||
|
2013
Q2 | $21K | Buy |
|